Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease.
about
Transient dynamics of Aβ contribute to toxicity in Alzheimer's diseaseOn the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP PeptidesTipping the Scale from Disorder to Alpha-helix: Folding of Amphiphilic Peptides in the Presence of Macroscopic and Molecular InterfacesChanges in membrane sphingolipid composition modulate dynamics and adhesion of integrin nanoclusters.Role of the fast kinetics of pyroglutamate-modified amyloid-β oligomers in membrane binding and membrane permeability.Curcumin Binding to Beta Amyloid: A Computational Study.Chirality-assisted ring-like aggregation of aβ(1-40) at liquid-solid interfaces: a stereoselective two-step assembly process.ALS-Causing Mutations Significantly Perturb the Self-Assembly and Interaction with Nucleic Acid of the Intrinsically Disordered Prion-Like Domain of TDP-43.Inhibitory effects of magnolol and honokiol on human calcitonin aggregation.Study of structural stability and damaging effect on membrane for four Aβ42 dimers.Amyloid-β adopts a conserved, partially folded structure upon binding to zwitterionic lipid bilayers prior to amyloid formationMonomeric Aβ(1-40) and Aβ(1-42) Peptides in Solution Adopt Very Similar Ramachandran Map Distributions That Closely Resemble Random Coil.A High Affinity Red Fluorescence and Colorimetric Probe for Amyloid β Aggregates.Lipid-Bilayer Dynamics Probed by a Carbon Dot-Phospholipid Conjugate.Neutron Scattering Studies of the Interplay of Amyloid β Peptide(1-40) and An Anionic Lipid 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol.Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.Metabolic relationship between diabetes and Alzheimer's Disease affected by Cyclo(His-Pro) plus zinc treatment.Molecular understanding of a potential functional link between antimicrobial and amyloid peptides.Amyloid-β peptides in interaction with raft-mime model membranes: a neutron reflectivity insight.Ultraviolet light triggers the conversion of Cu2+-bound Aβ42 aggregates into cytotoxic species in a copper chelation-independent manner.β-Amyloid-acetylcholine molecular interaction: new role of cholinergic mediators in anti-Alzheimer therapy?Structure based aggregation studies reveal the presence of helix-rich intermediate during α-Synuclein aggregation.Modeling the Aggregation Propensity and Toxicity of Amyloid-β Variants.Aggregation of Beta-Amyloid Peptides Proximal to Zwitterionic Lipid Bilayers.Shear-Induced Amyloid Formation in the Brain: II. An Experimental System for Monitoring Amyloid Shear Processes and Investigating Potential Spinal Tap Problems.Interfacial interaction and lateral association of cross-seeding assemblies between hIAPP and rIAPP oligomers.Structure of the transmembrane domain of human nicastrin-a component of γ-secretase.Insulin-degrading enzyme prevents α-synuclein fibril formation in a nonproteolytical manner.Extracellular vesicles from human pancreatic islets suppress human islet amyloid polypeptide amyloid formation.Small molecule NPT-440-1 inhibits ionic flux through Aβ1-42 pores: Implications for Alzheimer's disease therapeutics.Small liposomes accelerate the fibrillation of amyloid β (1-40).Interaction with prefibrillar species and amyloid-like fibrils changes the stiffness of lipid bilayers.Amyloid β Ion Channels in a Membrane Comprising Brain Total Lipid Extracts.Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β.Modulation of Alzheimer's amyloid β peptide oligomerization and toxicity by extracellular Hsp70.Model membrane size-dependent amyloidogenesis of Alzheimer's amyloid-β peptides.The size-effect of gold nanoparticles and nanoclusters in the inhibition of amyloid-β fibrillation.Environment-transformable sequence-structure relationship: a general mechanism for proteotoxicity.Toward a Soluble Model System for the Amyloid State.Binding of protofibrillar Aβ trimers to lipid bilayer surface enhances Aβ structural stability and causes membrane thinning.
P2860
Q26827421-D05C0823-0F7A-41A4-8587-209474887515Q27022467-35FBB0B6-C14F-4C74-BDBD-AC74F93838B0Q27318564-8528385F-4A22-4AB5-9E32-BEBF16315E7EQ27350099-F8CFF68D-5CBA-4EB2-9EBA-61755BB4108CQ34434154-E3E5DB72-0807-4157-8279-317DFD8E5B38Q34668648-6EECBBF9-2862-430E-B16F-8F0F51BD5F5CQ35532706-64E4EE2C-7195-4016-BC2C-1DECBE1A4F69Q35886826-DDC1C6D0-FAD9-4201-9779-CFE4F1748A44Q36012254-0F0EC0BB-552D-4711-AFFA-459ACF40E1BBQ36395898-98195114-BC2C-4756-B4A3-DABEAA607CF7Q36437225-14EA34D8-7B90-4B49-90AB-468BE4D2DA34Q36569893-7F955DFA-7ECE-43EC-AD11-2B9C2F58B37CQ36754686-135538D9-2FE9-4393-BDE1-72D7FC81D874Q37082146-33C8FA3F-B46F-4612-8550-26224AA2C1ECQ37199192-9E5CD2F4-74AD-4C6E-90B7-16624921F912Q37398112-EF81B43A-28B1-4357-A2B8-7CB8F77854E9Q37569276-AD9C8386-9C75-4D83-BEA5-A0D673065BFAQ38238202-83B72A85-FEE6-4BE7-AA53-1963D29C9262Q38477716-F245B281-A22D-4361-A23D-78C95056ED8EQ38836859-84C7C8F7-06CE-42CF-A232-7A108CEB5348Q38842924-2DC04048-0370-4394-A74E-043502A6468FQ38898283-FD269678-33E6-4D9A-99FB-441783FBD7D4Q40506178-AB44441E-A806-402C-B16B-6CC4987D4D29Q40813650-F04DC5FA-9C43-496C-B573-F514AE2D5E8BQ41102931-5CD5AE14-4587-4978-BE78-00E2B0ACF5DBQ41367406-453C4E28-C73B-490F-A8DC-0FF561CC7202Q42155167-73825B5F-7BEC-4102-A966-14784DCAED1EQ42409261-862CF1E2-E8F5-4521-B87E-A016C97AC2B4Q42653482-CE1FC0E3-9495-4CC9-9A58-C5913637846DQ42756593-1AC8A8A8-EB00-4B64-B660-5FEF95110D89Q43106231-0E2F31AD-C699-48FF-AB66-0ADF3D7CE72FQ46287013-5F5FE97C-2A3D-4F31-BB79-B11100A0CA6CQ46294211-B7B7FD7C-6E35-428B-8FBF-965BAD53260CQ46423931-35E2FEB3-DA76-4B76-B676-A6CBFEA68955Q46732603-819FBD03-2583-49F8-9D4A-BA181974CD8BQ47206608-05F3B215-B4C3-465A-A57B-81AB12EC0300Q47229854-BA5A1405-2803-48F5-A7B5-19569AF96CACQ47330876-2B37D3D3-BD0A-4CE0-9EF2-FCEDD15399F9Q47425256-DFA17A51-736F-4491-8052-ACDA96AD85A1Q47565192-EAE3DC58-D2B1-4C52-90F9-5D5B58E0D1C3
P2860
Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Differences between amyloid-β ...... etails of Alzheimer's disease.
@ast
Differences between amyloid-β ...... etails of Alzheimer's disease.
@en
type
label
Differences between amyloid-β ...... etails of Alzheimer's disease.
@ast
Differences between amyloid-β ...... etails of Alzheimer's disease.
@en
prefLabel
Differences between amyloid-β ...... etails of Alzheimer's disease.
@ast
Differences between amyloid-β ...... etails of Alzheimer's disease.
@en
P2860
P50
P356
P1476
Differences between amyloid-β ...... details of Alzheimer's disease
@en
P2093
Samuel A Kotler
P2860
P304
P356
10.1039/C3CS60431D
P577
2014-10-01T00:00:00Z